Form 4: Guardant Health Executive Chris Freeman Reports Stock Transactions
SEC Form 4 Filing
Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On July 1, 2024, Chris Freeman, the Chief Commercial Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- Freeman acquired 1,928 shares of common stock through the vesting of restricted stock units.
- Simultaneously, 758 shares were withheld by the company to cover tax obligations related to the vesting.
- Following these transactions, Freeman directly owns 25,769 shares of Guardant Health common stock and 17,356 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation and tax withholding.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of restricted stock unit award grant. |
| October 1, 2023 | 25% of the restricted stock units vested. |
| July 1, 2024 | Date of stock transactions: vesting of restricted stock units and tax withholding. |
| July 2, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.